Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;32(16):2059-66.
doi: 10.1093/eurheartj/ehp034. Epub 2009 Feb 19.

Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis

Affiliations

Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis

Young Joon Hong et al. Eur Heart J. 2011 Aug.

Abstract

Aims: We used virtual histology-intravascular ultrasound (VH-IVUS) to evaluate the relation between coronary plaque characteristics and no-reflow in acute coronary syndrome (ACS) patients.

Methods and results: A total of 190 consecutive ACS patients were imaged using VH-IVUS and analysed retrospectively. Angiographic no-reflow was defined as TIMI flow grade 0, 1, and 2 after stenting. Virtual histology-intravascular ultrasound classified the colour-coded tissue into four major components: fibrotic, fibro-fatty, dense calcium, and necrotic core (NC). Thin-cap fibroatheroma (TCFA) was defined as focal, NC-rich (≥10% of the cross-sectional area) plaques being in contact with the lumen in a plaque burden≥40%. Of the 190 patients studied at pre-stenting, no-reflow was observed in 24 patients (12.6%) at post-stenting. The absolute and %NC areas at the minimum lumen sites (1.6±1.2 vs. 0.9±0.8 mm2, P<0.001, and 24.5±14.3 vs. 16.1±10.6%, P=0.001, respectively) and the absolute and %NC volumes (30±24 vs. 16±17 mm3, P=0.001, and 22±11 vs. 14±8%, P<0.001, respectively) were significantly greater, and the presence of at least one TCFA and multiple TCFAs within culprit lesions (71 vs. 36%, P=0.001, and 38 vs. 15%, P=0.005, respectively) was significantly more common in the no-reflow group compared with the normal-reflow group. In the multivariable analysis, %NC volume was the only independent predictor of no-reflow (odds ratio=1.126; 95% CI 1.045-1.214, P=0.002).

Conclusion: In ACS patients, post-stenting no-reflow is associated with plaque components defined by VH-IVUS analysis with larger NC and more TCFAs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The absolute (A) and relative (B) plaque components at the minimum lumen site. Virtual histology-intravascular ultrasound analysis classified the colour-coded tissue into four major components: green [fibrotic (FT)]; yellow-green [fibro-fatty (FF)]; white [dense calcium (DC); and red [necrotic core (NC)]. At the minimum lumen site, the absolute and relative necrotic core areas and the absolute dense calcium area were significantly greater in the no-reflow group than in the normal-reflow group; conversely the relative fibro-fatty area was significantly smaller in the no-reflow group than in the normal-reflow group.
Figure 2
Figure 2
The absolute (A) and relative (B) plaque components at the largest necrotic core site. Virtual histology-intravascular ultrasound analysis classified the colour-coded tissue into four major components: green [fibrotic (FT)]; yellow-green [fibro-fatty (FF)]; white [dense calcium (DC); and red [necrotic core (NC)]. At the largest necrotic core site, the absolute and relative necrotic core areas and absolute dense calcium area were significantly greater in the no-reflow group than in the normal-reflow group; conversely relative fibrotic and fibro-fatty areas were significantly smaller in the no-reflow group than in the normal-reflow group.
Figure 3
Figure 3
The volumetric absolute (A) and relative (B) plaque components. Virtual histology-intravascular ultrasound analysis classified the colour-coded tissue into four major components: green [fibrotic (FT)]; yellow-green [fibro-fatty (FF)]; white [dense calcium (DC); and red [necrotic core (NC)]. The absolute and relative necrotic core and dense calcium volumes were significantly greater in the no-reflow group than in the normal-reflow group; conversely relative fibrotic and fibro-fatty volumes were significantly smaller in the no-reflow group than in the normal-reflow group.
Figure 4
Figure 4
The relative plaque components at the proximal (A) and distal (B) reference sites. Virtual histology-intravascular ultrasound analysis classified the colour-coded tissue into four major components: green [fibrotic (FT)]; yellow-green [fibro-fatty (FF)]; white [dense calcium (DC); and red [necrotic core (NC)]. At the proximal reference sites, the relative necrotic core and fibrotic areas were significantly greater in the no-reflow group than in the normal-reflow group; conversely relative fibro-fatty area was significantly smaller in the no-reflow group than in the normal-reflow group. At the distal reference sites, the relative necrotic core and dense calcium areas were significantly greater in the no-reflow group than in the normal-reflow group.
Figure 5
Figure 5
The incidence of thin-cap fibroatheromas. Virtual histology-intravascular ultrasound-detected thin-cap fibroatheroma was defined as a necrotic core ≥10% of plaque area in at least three consecutive frames without overlying fibrous tissue in the presence of ≥40% plaque burden. The presence of at least one thin-cap fibroatheroma and multiple thin-cap fibroatheromas within culprit lesions was more common in the no-reflow group than in the normal-reflow group.

Similar articles

Cited by

References

    1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. A meta analysis. JAMA. 1997;278:2093–2098. - PubMed
    1. Suryapranata H, van ‘t Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 1998;97:2502–2505. - PubMed
    1. Mahdi NA, Lopez J, Leon M, Pathan A, Harrell L, Jang IK, Palacios IF. Comparison of coronary stenting to primary balloon angioplasty with stent bail out for the treatment of patients with acute myocardial infarction. Am J Cardiol. 1998;81:957–963. - PubMed
    1. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP, Jr, Kuntz RE, Baim DS. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation. 1994;89:2514–2518. - PubMed
    1. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, Kondo J, Tsuboi H, Sassa H. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995;130:239–243. - PubMed

Publication types